AGTC Receives Grant from the Foundation Fighting Blindness for Pre-Clinical Study of Gene Therapy for Eye Disease

Biotechnology company AGTC has received a grant from the Foundation Fighting Blindness to fund a pre-clinical trial evaluating the safety and efficacy of a gene therapy treatment for a genetic eye disease affecting more than 35,000 patients.... [more]

View complete Press Release article